![]() |
Study: Myriad myRisk Hereditary Cancer test identifies 43 percent more patients with
Myriad Genetics, Inc. has announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46 percent in patients with breast...
More... |
| All times are GMT -7. The time now is 10:51 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021